Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU

被引：0
作者：
Roberta Joppi
Vittorio Bertele’
Silvio Garattini
机构：
[1] Mario Negri Institute for Pharmacological Research,Laboratory of Drug Regulatory Policies
[2] Local Health Unit of Verona,Pharmaceutical Department
来源：
European Journal of Clinical Pharmacology | 2013年 / 69卷
关键词：
Orphan drug; Rare disease; Pharmacological research; Drug regulation; Development; Preclinical studies; Clinical trials; Clinical efficacy; Placebo; Outcome measures;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1009 / 1024
页数：15
相关论文
共 50 条
  • [1] Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU
    Joppi, Roberta
    Bertele', Vittorio
    Garattini, Silvio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 1009 - 1024
  • [2] ORPHAN DRUGS
    Fontanet Sacristan, Juan Manuel
    Torrent-Farnell, Josep
    ARBOR-CIENCIA PENSAMIENTO Y CULTURA, 2018, 194 (789)
  • [3] Orphan drug legislation: lessons for neglected tropical diseases
    Villa, Stefano
    Compagni, Amelia
    Reich, Michael R.
    INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2009, 24 (01) : 27 - 42
  • [4] Drug repositioning for orphan diseases
    Sardana, Divya
    Zhu, Cheng
    Zhang, Minlu
    Gudivada, Ranga C.
    Yang, Lun
    Jegga, Anil G.
    BRIEFINGS IN BIOINFORMATICS, 2011, 12 (04) : 346 - 356
  • [5] Development of orphan drugs for rare diseases
    Yoo, Han-Wook
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2024, 67 (07) : 315 - 327
  • [6] The challenges of pharmacoepidemiology of orphan drugs in rare diseases
    Lapeyre-Mestre, Maryse
    THERAPIE, 2020, 75 (02): : 215 - 220
  • [7] EU marketing authorization review of orphan and non-orphan drugs does not differ
    Putzeist, M.
    Mantel-Teeuwisse, A. K.
    Llinares, J.
    Gispen-De Wied, C. C.
    Hoes, A. W.
    Leufkens, H. G. M.
    DRUG DISCOVERY TODAY, 2013, 18 (19-20) : 1001 - 1006
  • [8] EMA approved orphan medicines since the implementation of the orphan legislation
    Eveliina Hahl
    Terhi Kurko
    Hanna Koskinen
    Marja Airaksinen
    Kati Sarnola
    Orphanet Journal of Rare Diseases, 20 (1)
  • [9] The availability and affordability of orphan drugs for rare diseases in China
    Shiwei Gong
    Yingxiao Wang
    Xiaoyun Pan
    Liang Zhang
    Rui Huang
    Xin Chen
    Juanjuan Hu
    Yi Xu
    Si Jin
    Orphanet Journal of Rare Diseases, 11
  • [10] Rare diseases and orphan drugs: 500 years ago
    Dooms, Marc M.
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
12345